Analysis reveals limited evidence on use of cannabis products in children with cancer

A recent analysis of all relevant published studies reveals a lack of evidence to determine the dosing, safety, and efficacy of medical marijuana or cannabis-containing products for managing symptoms experienced by children with cancer.

Bristol Myers Squibb reports 6% drop in Q2 2023 revenues

BMS updated its 2023 guidance, with the total revenues now expected to see a low single-digit reduction. Credit: Tada Images / Shutterstock.com. Bristol Myers Squibb

July 28, 2023

Older Americans living alone often rely on neighbors or others willing to help

Donald Hammen, 80, and his longtime next-door neighbor in south Minneapolis, Julie McMahon, have an understanding. Every morning, she checks to see whether he’s raised

November 12, 2024

U.K. pharma increasingly violates voluntary industry marketing codes, and probes are taking longer

Pharmaceutical companies in the U.K. have increasingly violated a voluntary industry marketing code but complaints are also taking longer to review, according to a new

June 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.